Infect Immun. 1993 February; 61(2): 491-497
Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells.
J Mayer,
M L Woods,
Z Vavrin and
J B Hibbs Jr
Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City 84132.
ABSTRACT
McCoy cells, murine-derived cells commonly used for propagation of chlamydiae, were found to be efficient producers of nitric oxide (NO) when primed with murine gamma interferon (IFN-gamma) and then exposed to the second signals provided by Escherichia coli lipopolysaccharide, human interleukin-1 alpha, murine tumor necrosis factor alpha, or Chlamydia trachomatis type H. Murine recombinant IFN-gamma over a range of 0 to 50 U/ml inhibited infectivity of C. trachomatis type H in a dose-dependent fashion in McCoy cells while simultaneously inducing NO production. Quantitation of infectious chlamydia progeny remaining in McCoy cells 48 or 72 h postinfection revealed that IFN-gamma-primed McCoy cells reduced chlamydial inclusion-forming units (expressed as units per milliliter) by 4 log10 units at higher IFN-gamma concentrations (50 U/ml) compared with control values. The magnitude of this antichlamydial effect was directly related to increased synthesis of NO, the production of which was IFN-gamma dose dependent. The antichlamydial effects of IFN-gamma were blocked in a dose-dependent manner by the addition of N-guanidino-monomethyl L-arginine (MLA), an inhibitor of nitric oxide synthesis. These results suggest that although IFN-gamma priming of McCoy cells is required for antichlamydial activity, nitric oxide is a necessary effector molecule involved in the mechanism(s) of IFN-gamma-induced inhibition of chlamydial proliferation in this murine cell line. The ability to block the potent antichlamydial effects of IFN-gamma by inhibition of a specific enzyme, nitric oxide synthase, may give insights into mechanisms by which IFN-gamma and perhaps other cytokines are able to control proliferation of chlamydiae and other intracellular pathogens.
Infect Immun. 1993 February; 61(2): 491-497
This article has been cited by other articles:
-
Roshick, C., Wood, H., Caldwell, H. D., McClarty, G.
(2006). Comparison of Gamma Interferon-Mediated Antichlamydial Defense Mechanisms in Human and Mouse Cells. Infect. Immun.
74: 225-238
[Abstract]
[Full Text]
-
Ramsey, K. H., Sigar, I. M., Rana, S. V., Gupta, J., Holland, S. M., Byrne, G. I.
(2001). Role for Inducible Nitric Oxide Synthase in Protection from Chronic Chlamydia trachomatis Urogenital Disease in Mice and Its Regulation by Oxygen Free Radicals. Infect. Immun.
69: 7374-7379
[Abstract]
[Full Text]
-
Ramsey, K. H., Miranpuri, G. S., Sigar, I. M., Ouellette, S., Byrne, G. I.
(2001). Chlamydia trachomatis Persistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome. Infect. Immun.
69: 5131-5137
[Abstract]
[Full Text]
-
Paavonen, J.
(2001). Chlamydia trachomatis and cancer. Sex. Transm. Infect.
77: 154-156
[Full Text]
-
Anttila, T., Saikku, P., Koskela, P., Bloigu, A., Dillner, J., Ikaheimo, I., Jellum, E., Lehtinen, M., Lenner, P., Hakulinen, T., Narvanen, A., Pukkala, E., Thoresen, S., Youngman, L., Paavonen, J.
(2001). Serotypes of Chlamydia trachomatis and Risk for Development of Cervical Squamous Cell Carcinoma. JAMA
285: 47-51
[Abstract]
[Full Text]
-
Rottenberg, M. E., Gigliotti Rothfuchs, A., Gigliotti, D., Ceausu, M., Une, C., Levitsky, V., Wigzell, H.
(2000). Regulation and Role of IFN-{gamma} in the Innate Resistance to Infection with Chlamydia pneumoniae. J. Immunol.
164: 4812-4818
[Abstract]
[Full Text]
-
Harper, A., Pogson, C. I., Jones, M. L., Pearce, J. H.
(2000). Chlamydial Development Is Adversely Affected by Minor Changes in Amino Acid Supply, Blood Plasma Amino Acid Levels, and Glucose Deprivation. Infect. Immun.
68: 1457-1464
[Abstract]
[Full Text]
-
Matsushima, H., Shirai, M., Ouchi, K., Yamashita, K., Kakutani, T., Furukawa, S., Nakazawa, T.
(1999). Lymphotoxin Inhibits Chlamydia pneumoniae Growth in HEp-2 Cells. Infect. Immun.
67: 3175-3179
[Abstract]
[Full Text]
-
Perry, L. L., Su, H., Feilzer, K., Messer, R., Hughes, S., Whitmire, W., Caldwell, H. D.
(1999). Differential Sensitivity of Distinct Chlamydia trachomatis Isolates to IFN-{gamma}-Mediated Inhibition. J. Immunol.
162: 3541-3548
[Abstract]
[Full Text]
-
Lampe, M. F., Wilson, C. B., Bevan, M. J., Starnbach, M. N.
(1998). Gamma Interferon Production by Cytotoxic T Lymphocytes Is Required for Resolution of Chlamydia trachomatis Infection. Infect. Immun.
66: 5457-5461
[Abstract]
[Full Text]
-
Muhlestein, J. B., Anderson, J. L., Hammond, E. H., Zhao, L., Trehan, S., Schwobe, E. P., Carlquist, J. F.
(1998). Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model. Circulation
97: 633-636
[Abstract]
[Full Text]
-
Ramsey, K. H., Miranpuri, G. S., Poulsen, C. E., Marthakis, N. B., Braune, L. M., Byrne, G. I.
(1998). Inducible Nitric Oxide Synthase Does Not Affect Resolution of Murine Chlamydial Genital Tract Infections or Eradication of Chlamydiae in Primary Murine Cell Culture. Infect. Immun.
66: 835-838
[Abstract]
[Full Text]
-
Hickman-Davis, J. M., Lindsey, J. R., Zhu, S., Matalon, S.
(1998). Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol.
274: L270-L277
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.